Story thread · 6 reports / 2 sources
Zimmer Biomet sales force revamp going better than expected, CEO says
medtechdive.com · 5d
How the coverage leans
Across 2 sources · syndicated copies counted once
The restructuring, intended to give Zimmer Biomet a fully dedicated sales force, is expected to be complete by the end of 2027.
First report: Douglas Dynamics forecasts 2026 adjusted EPS of $2.90 to $3.40 as it raises net sales outlook to $765M-$805M — seekingalpha.com, 8d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.